CELLPOINT Latest Share Price (CELLPOINT)
How good is this company?
Overall performance across 5 key dimensions.
CELLPOINT flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 0.1%
Latest CELLPOINT News
What changed recently?
Recent events, corporate actions, and announcements.
CELLPOINT valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for CELLPOINT, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
CELLPOINT technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for CELLPOINT — derived from the latest tape, not yesterday's close.
Pivot points
Insufficient OHLC data to compute pivots.
CPR cannot be computed without OHLC.
CELLPOINT financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for CELLPOINT — consolidated or standalone — with margins, YoY growth and key ratios inline.
CELLPOINT reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹27.93 Cr. and reported EPS of ₹0.03.
CELLPOINT segment analysis : revenue and profit mix.
Disclosed business segments at CELLPOINT with their share of revenue and profit, switchable between consolidated and standalone reporting.
CELLPOINT discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for CELLPOINT.
Our AI distills the core fundamental drivers supporting CELLPOINT, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.54. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
CELLPOINT peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — CELLPOINT is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
CELLPOINT chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for CELLPOINT — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
CELLPOINT delivery volume — last 20 sessions of conviction.
No volume or delivery data on record.
CELLPOINT announcements: results, concalls, ratings, M&A.
Filings CELLPOINT sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
CELLPOINT files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 26 documents below.
Press Release
Cell Point (India) Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "NEWSPAPER ADVERTISEMENT FOR 13th…
General Updates
Cell Point (India) Limited has informed the Exchange about CORRIGENDUM TO ANNUAL REPORT 2026
Corrigendum
Cell Point (India) Limited has informed the Exchange regarding Corrigendum to Notice of Annual General Meeting to be held on September 29, 2026
Updates
Cell Point (India) Limited has informed the Exchange regarding 'Scrutinizer Appointment'. for E-voting/Physical Voting at 13th AGM
Shareholders meeting
Cell Point (India) Limited has informed the Exchange regarding Notice of 13th Annual General Meeting to be held on September 29, 2026
CELLPOINT dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue CELLPOINT has declared, sequenced by announce and record date.
CELLPOINT corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About CELLPOINT: business, sector, key facts.
What CELLPOINT does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
CELLPOINT is a listed Indian equity.
CELLPOINT
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- ADITYA BIRLA LIFES BRAN L (ABLBL) Share PricePeer
- ADVENT HOTELS INTERNATI L (ADVENTHTL) Share PricePeer
- AHLWEST (AHLWEST) Share PricePeer
- APOLLO SINDOORI HOTEL (APOLSINHOT) Share PricePeer
- BLUE COAST HOTELS (BLUECOAST) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about CELLPOINT (CELLPOINT).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of CELLPOINT (CELLPOINT)?
The current share price of CELLPOINT (CELLPOINT) is ₹0.00. Today, the stock has gained by ₹0.00 (0%), trading in a range of ₹0.00 to ₹0.00. The stock opened at ₹0.00 with a trading volume of 0 shares.
02What is the dividend yield of CELLPOINT and when is the next dividend?
CELLPOINT offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹0.00, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
03How is CELLPOINT stock performing today in the market?
CELLPOINT stock opened at ₹0.00 and is currently trading at ₹0.00, showing a gain of ₹0.00 (0%). The intraday high is ₹0.00 and low is ₹0.00. The trading volume stands at 0 shares, indicating moderate market participation today.
04What is the market capitalization of CELLPOINT?
CELLPOINT has a market capitalization of ₹27.93 Cr., making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹0.00) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
05What is the ROE and ROCE of CELLPOINT?
CELLPOINT has a Return on Equity (ROE) of 0.09% and Return on Capital Employed (ROCE) of 0.34%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
06Which sector and industry does CELLPOINT belong to?
CELLPOINT operates in the broader sector and belongs to the its industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
07What is the debt-to-equity ratio of CELLPOINT?
CELLPOINT has a debt-to-equity ratio of 1.04, which measures the company's financial leverage by comparing total debt to shareholders' equity. A ratio above 1 suggests the company uses more debt than equity for financing. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
08What is the sales and profit growth of CELLPOINT?
CELLPOINT has reported a sales growth of 0% and profit growth of -66.67%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
The data, ratios and commentary about CELLPOINT (CELLPOINT) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.